Diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are diagnosed with type 2 diabetes. 2) Patients who aged 20 years or older at the time of acquiring consent 3) Patients who are expected to survive for more than 1 year from the date of registration. 4) Surgery is not received within 6 months before the registration date, or registration Patients who are not planning to undergo surgery within the next 6 months. 5) Patient with written informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who participated in other trials within one year before consent acquisition 2) Others, patients who are judged not eligible for this research by responsible investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in HbA1c value (NGSP value) | — |
Secondary
| Measure | Time frame |
|---|---|
| Transition of eGFR value, side effects of diabetes remedy drugs and major cardiovascular events | — |
Countries
Japan
Contacts
Hamamatsu University School of Medicine Department of Clinical Pharmacology and Therapeutics